(R)-2-(Fluoromethyl)pyrrolidine hydrochloride, 97%, 5g

N-(p-Toluenesulfonyl)-L-phenylalanine, 95.0%, 25g

N-(4-Methoxyphenyl)-1-phenyl-1H-pyrazol-3-amine, 95.0%, 25mg

1-Bromo-8-methylnaphthalene, 97%, 5g

Sodium (S)-2-(6-methoxynaphthalen-2-yl)propanoate, 98.0%, 5g

Objectif Plan PLi 2x/0.05 IOS corrigé à l'infini, pas de correction du verre de protection. Distance de travail 18,3 mm

1-[2-(4-chlorophenyl)ethyl]-1H-1,3-benzodiazol-5-amine, 95.0%, 250mg

2-{5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl}acetic acid, 95+%, 100mg

(1R)-1-(Thiophen-2-yl)ethan-1-amine, 95.0%, 100mg

Methyl-beta-D-xylopyranoside, 96.0%, 10g

Sodium 4,4'-oxybis(butane-1-sulfonate), 95.0%, 1g

5''-(4'-Amino-[1,1'-biphenyl]-4-yl)-[1,1':4',1'':3'',1''':4''',1''''-quinquephenyl]-4,4''''-diamine, 95%, 250mg

N-Methylpyrazole, 99.0%, 5g